跳至主要内容
临床试验/IRCT20190903044682N1
IRCT20190903044682N1已完成3 期

Effect of Atorvastatin versus Rosuvastatin on level of inflammatory markers and low density lipoprotein-cholesterol (LDL) in Patients with acute coronary syndrome: double blind randomize control trial

eyshabour University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Acute coronary syndrome based on clinical signs and ECG and serum markers

排除标准

  • renal failure
  • Liver failure
  • Immunosuppressants, corticosteroids or potent inhibitors of cytochrome P450 3A4, pentoxifylline, silostazole, glucosamine, berberine barberry extract
  • Having underlying inflammatory or infectious diseases
  • Left Schiff's Leukostosis
  • CHF with NYHA III or IV
  • Having a history of diseases that cause malabsorption syndromes
  • Uncontrolled blood pressure
  • Evidence of endocrine or metabolic disease affecting lipid profile

研究者

发起方
eyshabour University of Medical Sciences

相似试验